The PDGFR and epidermal growth factor receptor (EGFR) groups of TK receptors have gained interest as plausible therapy targets for respiratory afflictions, as these receptors have been shown to perform important functions in persistent tissue repair in respiratory fibrosis, bronchitis, and asthma [154]. Here, EGFR is linked to bronchitis.